Showing results (231-240 of 330) with videos related to

Sort By:
Pageof 33
Radiology|October 1, 1991
Invasion of the neurovascular bundle by prostate cancer: evaluation with MR imagingC M Tempany, A D Rahmouni, J I Epstein, et al.
Urology|April 1, 1997
Incidence and clinical significance of high-grade prostatic intraepithelial neoplasia in TURP specimensP B Gaudin, I A Sesterhenn, K J Wojno, et al.
JAMA|May 14, 1997
Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancerH B Carter, J I Epstein, D W Chan, et al.
The Journal of Urology|May 1, 1988
Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sectionsJ L Mohler, A W Partin, J I Epstein, et al.
Urologic Oncology|February 5, 2017
Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ, Carter HB.J Clin Oncol. 2015 Oct 20;33(30):3379-85. [Epub 2015 Aug 31]. doi: 10.1200/JCO.2015.62.5764Eggener Scott, M Mamawala, J I Epstein, et al.
Urology|June 4, 1998
A quantitative histologic analysis of collagen subtypes: the primary obstructed and refluxing megaureter of childhoodB R Lee, R I Silver, A W Partin, et al.
The Journal of Urology|March 1, 1995
Pathological features of hereditary prostate cancerS I Bastacky, K J Wojno, P C Walsh, et al.
The American Journal of Surgical Pathology|April 24, 2004
Prostate carcinoma with squamous differentiation: an analysis of 33 casesAnil V Parwani, J D Kronz, E M Genega, et al.
Urology|August 8, 2001
Prognostic assessment of nonmetastatic renal cell carcinoma: a clinically based modelO Yaycioglu, W W Roberts, T Chan, et al.
Cancer Research|January 15, 1993
Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brainR J Tamargo, J S Myseros, J I Epstein, et al.
Pageof 33